Drug Induced Dyskinesia

Symptoms, Doctors, Treatments, Research & More

Condition 101

What is the definition of Drug Induced Dyskinesia?

Drug induced dyskinesia is an involuntary movement disorder. Signs and symptoms include repetitive and irregular motions of the mouth, face, limbs and/or trunk. Treatment with antipsychotic drugs and levodopa (commonly used to treat Parkinson disease) are well recognized causes of drug-induced dyskinesia. Dyskinesia develops in around 40% of people with Parkinson's disease who have been on levodopa treatment for four to six years. Tardive dyskinesia is a severe form of drug-induced dyskinesia due to antipsychotic treatments. Tardive dyskinesia develops in 5% of people per year of treatment.

What are the alternative names for Drug Induced Dyskinesia?

  • Dyskinesia, drug induced

What are the causes for Drug Induced Dyskinesia?

The following medications have caused drug-induced dyskinesia in some individuals:

  • Levodopa
  • Chlorpromazine
  • Fluphenazine
  • Haloperidol
  • Trifluoperazine
  • Flunarizine (Sibelium)
  • Metoclopramide
  • Prochlorperazine

Latest Research

Latest Advance
  • Condition: Huntington Disease (HD)
  • Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • Treatment Used: Medical Marijuana
  • Number of Patients: 0
  • Published —
This review of the literature evaluated the effects of medical marijuana on symptoms that are relevant to movement disorders, focusing on Huntington disease (HD).
Latest Advance
  • Condition: Patients with Freely Moving Essential Tremor (ET)
  • Journal: Journal of neural engineering
  • Treatment Used: Fully Implanted Adaptive Deep Brain Stimulation (DBS)
  • Number of Patients: 2
  • Published —
This study collected data on fully implanted adaptive deep brain stimulation in patients with freely moving essential tremor.

Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Study Type: Procedure
  • Participants: 45
  • Start Date: October 2021
A Clinical Research on the Safety/Efficacy of Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia
Clinical Trial
  • Status: Not yet recruiting
  • Study Type: Other
  • Participants: 66
  • Start Date: April 1, 2021
Perioperative Evaluation of Cerebellar Tumors: Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia